blyleven

Bert Blyleven: let the PED users in the Hall of Fame

7 Comments

I wrote yesterday about how I reconcile PED use and the Hall of Fame.  I’ve written a lot about Bert Blyleven and the Hall of Fame. Say, how can those things go together?

Via the Jonah Keri Podcast, of course.  Jonah has been talking to some serious heavyweights this week, and the other day Blyleven gave Jonah a half hour of his time.  It’s all worth listening to, but I think the most interesting part is when they talk about steroid users and the Hall. Blyleven’s take? Let McGwire, Bonds and Clemens in. His rationale (more or less) is that a lot of guys were taking and they all didn’t become Hall of Famers, so why degrade the accomplishments of the ones who did? This is a rough approximation of my own stance: sure, guys used PEDs, but it’s not like that prevents us from distinguishing them from other players and recognizing their greatness. At least if we don’t take a blanket “no PED users in the Hall” approach.  Which I think is extremely problematic.

Not that Blyleven and I agree on everything.  He would change his mind on Bonds or Clemens if they were to be convicted in their respective criminal prosecutions. Hard to say if he thinks that’s because that would officially make them criminals and thus disqualify them on moral grounds or, alternatively, if it would merely remove some extant doubt from his mind about what they did while they played.  Bert is also part of the “release all the names” club which, as I have argued is simply wrong.

But however he comes down, it’s a good interview and a good window on how hard it is to figure out what to do with the Hall of Fame in the wake of the steroid era.

Brett Lawrie will take a pay cut to avoid arbitration with White Sox

MIAMI, FL - AUGUST 12: Brett Lawrie #15 of the Chicago White Sox fields a ground ball during batting practice before the start of the game against the Miami Marlins at Marlins Park on August 12, 2016 in Miami, Florida. (Photo by Eric Espada/Getty Images)
Getty Images
1 Comment

Infielder Brett Lawrie successfully avoided arbitration and signed a one-year contract with the White Sox on Friday, per a team announcement. FanRag Sports’ Jon Heyman added that the deal was for $3.5 million, significantly lower than the $4.125 million Lawrie was paid by the White Sox in 2016.

The White Sox acquired Lawrie last December in a swap for minor league arms Zack Erwin and J.B. Wendelken. After splitting time at second and third base for the Athletics in 2015, Lawrie slotted in at second base and DH for the White Sox and batted .248/.310/.413 with 12 home runs in 384 PA. While it’s strange to see a healthy, fairly productive player receive a salary reduction in arbitration, Lawrie missed nearly half of the season with a strain in his left hamstring, though he’s projected to return at full health by the start of the 2017 season.

Cubs sign LHP Brian Duensing to a one-year, $2 million deal

TORONTO, ON - OCTOBER 04:  Brian Duensing #50 of the Baltimore Orioles throws a pitch in the eleventh inning against the Toronto Blue Jays during the American League Wild Card game at Rogers Centre on October 4, 2016 in Toronto, Canada.  (Photo by Tom Szczerbowski/Getty Images)
Getty Images
Leave a comment

Left-hander Brian Duensing signed a one-year, $2 million contract with the Cubs on Friday, per a report from FanRag Sports’ Jon Heyman.

The free agent spent the bulk of his 2016 season with the Orioles after receiving a call-up from Triple-A Norfolk in early June. He underwent elbow surgery several weeks later when a freak bullpen injury revealed cartilage chips and inflammation in his pitching elbow, but recovered to finish the season with a 4.05 ERA and 10 strikeouts in 13 1/3 innings for the club. The Orioles utilized him for a final out during the AL Wild Card game, during which Duensing recorded a five-pitch strikeout in the ninth inning of their 5-2 loss to the Blue Jays.

The 33-year-old is currently expected to bulk up the Cubs’ left-handed relief corps, with fellow left-hander Mike Montgomery slated for the rotation in 2017.